Benjamin R Yerxa - Net Worth and Insider Trading
Benjamin R Yerxa Net Worth
The estimated net worth of Benjamin R Yerxa is at least $421,563 dollars as of 2024-12-28. Benjamin R Yerxa is the President of Opus Genetics Inc and owns about 342,800 shares of Opus Genetics Inc (IRD) stock worth over $404,504. Benjamin R Yerxa is also the Director of Clearside Biomedical Inc and owns about 17,957 shares of Clearside Biomedical Inc (CLSD) stock worth over $17,059. Details can be seen in Benjamin R Yerxa's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Benjamin R Yerxa has not made any transactions after 2024-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Benjamin R Yerxa
Benjamin R Yerxa Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Benjamin R Yerxa owns 1 companies in total, including Clearside Biomedical Inc (CLSD) .
Click here to see the complete history of Benjamin R Yerxa’s form 4 insider trades.
Insider Ownership Summary of Benjamin R Yerxa
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLSD | Clearside Biomedical Inc | 2024-05-15 | director |
Benjamin R Yerxa Latest Holdings Summary
Benjamin R Yerxa currently owns a total of 2 stocks. Among these stocks, Benjamin R Yerxa owns 342,800 shares of Opus Genetics Inc (IRD) as of November 21, 2024, with a value of $404,504 and a weighting of 95.95%. Benjamin R Yerxa also owns 17,957 shares of Clearside Biomedical Inc (CLSD) as of May 15, 2024, with a value of $17,059 and a weighting of 4.05%.
Latest Holdings of Benjamin R Yerxa
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IRD | Opus Genetics Inc | 2024-11-21 | 342,800 | 1.18 | 404,504 |
| CLSD | Clearside Biomedical Inc | 2024-05-15 | 17,957 | 0.95 | 17,059 |
Holding Weightings of Benjamin R Yerxa
Benjamin R Yerxa Form 4 Trading Tracker
According to the SEC Form 4 filings, Benjamin R Yerxa has made a total of 1 transactions in Opus Genetics Inc (IRD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Opus Genetics Inc is the acquisition of 10,000 shares on November 21, 2024, which cost Benjamin R Yerxa around $9,800.
According to the SEC Form 4 filings, Benjamin R Yerxa has made a total of 1 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Clearside Biomedical Inc is the acquisition of 7,813 shares on May 15, 2024, which cost Benjamin R Yerxa around $10,235.
Insider Trading History of Benjamin R Yerxa
- 1
Benjamin R Yerxa Trading Performance
GuruFocus tracks the stock performance after each of Benjamin R Yerxa's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Benjamin R Yerxa is -20.08%. GuruFocus also compares Benjamin R Yerxa's trading performance to market benchmark return within the same time period. The performance of stocks bought by Benjamin R Yerxa within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Benjamin R Yerxa's insider trading performs compared to the benchmark.
Performance of Benjamin R Yerxa
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.21 |  | | | | |
| Relative Return to S&P 500(%) | -6.23 | | | | | |
Benjamin R Yerxa Ownership Network
Benjamin R Yerxa Owned Company Details
What does Clearside Biomedical Inc do?
Who are the key executives at Clearside Biomedical Inc?
Benjamin R Yerxa is the director of Clearside Biomedical Inc. Other key executives at Clearside Biomedical Inc include 10 percent owner Bradford T Whitmore , Chief Financial Officer Charles A. Deignan , and director & 10 percent owner Clay Thorp .
Clearside Biomedical Inc (CLSD) Insider Trades Summary
Over the past 18 months, Benjamin R Yerxa made 1 insider transaction in Clearside Biomedical Inc (CLSD) with a net purchase of 7,813. Other recent insider transactions involving Clearside Biomedical Inc (CLSD) include a net purchase of 90,000 shares made by , a net purchase of 580,222 shares made by Bradford T Whitmore , and a net purchase of 100,000 shares made by Anthony S Gibney .
In summary, during the past 3 months, insiders sold 0 shares of Clearside Biomedical Inc (CLSD) in total and bought 36,500 shares, with a net purchase of 36,500 shares. During the past 18 months, 30,900 shares of Clearside Biomedical Inc (CLSD) were sold and 798,035 shares were bought by its insiders, resulting in a net purchase of 767,135 shares.
Clearside Biomedical Inc (CLSD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clearside Biomedical Inc Insider Transactions
Benjamin R Yerxa Mailing Address
Above is the net worth, insider trading, and ownership report for Benjamin R Yerxa. You might contact Benjamin R Yerxa via mailing address: Inspire Pharmaceuticals, Inc.,, 4222 Emperor Blvd., Ste. 470, Durham Nc 27703-8466.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
